Andriy Marusyk1, James DeGregori
1Department of Biochemistry and Molecular Genetics, Program in Molecular Biology, University of Colorado at Denver Health Sciences Center, Aurora, Colorado 80045, USA.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Disrupting the tumor suppressor p53 (also known as TP53) can provide a proliferative advantage under replicational stress, potentially driving cancer evolution and chemoresistance. Understanding this selection pressure is key for developing new cancer therapies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: